Home/Filings/4/0001017632-05-000001
4//SEC Filing

OMARA JOHN M 4

Accession 0001017632-05-000001

CIK 0000009346other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 11:41 AM ET

Size

20.7 KB

Accession

0001017632-05-000001

Insider Transaction Report

Form 4
Period: 2005-01-03
OMARA JOHN M
Director
Transactions
  • Exercise/Conversion

    Class B Common

    2005-01-03$28.69/sh+1,047$30,03866,176 total
  • Award

    Right to buy (option)

    2004-04-01$29.39/sh+229$6,730229 total
    Exercise: $1.00From: 2005-04-02Exp: 2014-04-01Class B Common (229 underlying)
  • Exercise of In-Money

    Right to buy (option)

    2005-01-03$26.89/sh1,047$28,1546,908 total
    Exercise: $0.80From: 1995-01-03Exp: 2013-01-03Class B Common (1,047 underlying)
  • Award

    Right to buy (option)

    2004-07-01$25.19/sh+269$6,776269 total
    Exercise: $1.00From: 2005-07-02Exp: 2014-07-01Class B Common (269 underlying)
  • Award

    Right to buy (option)

    2004-10-01$25.43/sh+205$5,213205 total
    Exercise: $1.00From: 2005-10-02Exp: 2014-10-01Class B Common (205 underlying)
  • Award

    Right to buy (option)

    2005-01-03$26.89/sh+251$6,749251 total
    Exercise: $1.00From: 2006-01-04Exp: 2015-01-03Class B Common (251 underlying)
Holdings
  • Class A Common

    (indirect: By Trust)
    57,375
  • Class A Common

    (indirect: By Spouse)
    13,875
  • Class A Common

    14,062
  • Right to buy (option)

    Exercise: $1.00From: 2004-04-02Exp: 2014-01-02Class B Common (752 underlying)
    752
Footnotes (5)
  • [F1]Reporting person serves as trustee and has or shares investment power but expressly disclaims beneficial ownership.
  • [F2]Reporting person disclaims beneficial ownership of these shares.
  • [F3]Options become exercisable one year from the date of issuance and expire ten years and one day from the date of issuance. Exercise price for all options was $1.00 per share on the date of grant. For options previously reported on Forms 4 and 5, the expiration dates range from January 3, 2005 to January 3, 2013. The price paid for the options was equal to and in lieu of directors fees.
  • [F4]Options become exercisable one year from the date of issuance and expire ten years and one day from the date of issuance. Exercise price for all options was $1.00 per share on the date of grant. For options previously reported on Forms 4 and 5, the expiration dates range from April 1, 2013 to January 2, 2014. The price paid for the options was equal to and in lieu of directors fees.
  • [F5]The price paid for the options was equal to and in lieu of directors fees in the amount of $3,000 to $4,500 per quarter.

Issuer

BALDWIN & LYONS INC

CIK 0000009346

Entity typeother

Related Parties

1
  • filerCIK 0001017632

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 11:41 AM ET
Size
20.7 KB